Levetiracetam is a drug within the pyrrolidine class that is used to treat various types of seizures stemming from epileptic disorders. It was first approved for use in the United States in 1999 and is structurally and mechanistically unrelated to other anti-epileptic drugs (AEDs).[L8606,L8600,L8615] Levetiracetam possesses a wide therapeutic index[L8615,A185918] and little-to-no potential to produce, or be subject to, pharmacokinetic interactions[L8606,L8600,L8615] - these characteristics make it a desirable choice over other AEDs, a class of drugs notorious for having generally narrow therapeutic indexes and a propensity for involvement in drug interactions.[A185927]
Synonyms
Levetiracetame
Levetiracetamum
Levetiracetam
Brand Names
LEVETIRACETAM Extended-release
PHL-levetiracetam
Levertiracetam
Keppra
Novo-levetiracetam
Levetiracetam in Sodium Chloride
Ran-levetiracetam
Pharma-levetiracetam
Van-levetiracetam
Apo-levetiracetam
Pro-levetiracetam - 500
Roweepra
Levetiracetam Injection USP
Keppra XR
Levetiracetam
Auro-levetiracetam
Levetiracetam ER
Roweepra XR
Levetiractam
Teva-levetiracetam
M-levetiracetam
Torrent-levetiracetam
Spritam
Levetiracetam Extended Release
Sandoz Levetiracetam
Levetiracetam Teva
Mint-levetiracetam
Jamp-levetiracetam
Elepsia XR 1500 mg
Levetiracetam Ratiopharm
Pro-levetiracetam - 250
Ava-levetiracetam
Levetiracetam Hospira
Ag-levetiracetam
LEVETIRACETAM solution
Jamp Levetiracetam Tablets
Levetiracetam Levetiracetam
Levetiracetam Extended-Release
Nat-levetiracetam
Levetiracetam Accord
Nra-levetiracetam
Levetiracetam Actavis
Elepsia XR
Dom-levetiracetam
Levetiracetam 750 mg
Levetiracetam 1000 mg
Levetiracetam Actavis Group
Nu-levetiracetam
Levetiracetam 250 mg
Ach-levetiracetam
Matever
Levetiracetam Extended-release
Pro-levetiracetam - 750
Levetiracetam extended-release
PMS-levetiracetam
Bio-levetiracetam
Elepsia XR 1000 mg
Levetiracetam Sun
Pdp-levetiracetam
Riva-levetiracetam
Priva-levetiracetam
Levetiracetam Micro
Abbott-levetiracetam
Indication
Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606] Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]
Categories
Acetamides
Amides
Anticonvulsants
Central Nervous System Agents
Central Nervous System Depressants
Decreased Central Nervous System Disorganized Electrical Activity
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682